Senti Biosciences is trading at $0.31, down 8.86%, as potential resale supply appears to pressure the stock during September 25 trading. - The company registered 25,555,024 shares for resale by existing securityholders, approximately 82.1% of outstanding shares. - The shares are tied to convertible notes issued in 2026. - The company will receive no proceeds from subsequent resales.